Yıl: 2021 Cilt: 17 Sayı: 1 Sayfa Aralığı: 48 - 52 Metin Dili: İngilizce DOI: 10.5222/BMJ.2021.43534 İndeks Tarihi: 20-05-2021

Can our Blood Groups Determine our Life Expectancy?

Öz:
Objective: In this study, we aimed to investigate the relationship between long-term mortality and survival in patients with ABO blood group, and acute coronary syndrome.Method: This observational study was carried out in two tertiary hospitals. A total of 192 patients followed up for 72 months due to acute coronary syndrome, and showing a balanced distribution for ejection fraction, additional diseases and age, were included in the study.Results: The survival rate was evaluated in 72 months of follow-up. In the survival analysis made according to individual blood groups; a statistically significant difference was not detected between groups. When the patients were divided into two groups, mortality rates were 24.39% in patients with, and 15.23% without blood group O (p>0.05). Although not statistically significant, in patients with blood group O, an increasing tendency was observed in 72 month-mortality rates (p>0.05). Any association between Rh antigen and survival was not found in this study (p=0.79).Conclusion: Although it could not reach the limit of statistical significance, a decreasing tendency in long-term survival was observed in acute coronary syndrome patients with blood group O compared to those without The results should be confirmed by larger prospective studies.
Anahtar Kelime:

Kan Gruplarımız Hayat Uzunluğumuzu Belirleyebilir mi?

Öz:
Amaç: Bu çalışmada akut koroner sendromlu hastalarda ABO kan grubu ile sağkalım ve uzun-süreli mortalite arasındaki ilişkiyi araştırmayı amaçladık.Yöntem: Bu gözlemsel çalışma, iki adet üçüncü basamak hastanede gerçekleştirildi. Ejeksiyon fraksiyonu, ek hastalıklar ve yaş için dengeli bir dağılım gösteren akut koroner sendrom nedeniyle 72 ay takip edilen 192 hasta çalışmaya dahil edildi.Bulgular: Sağkalım oranı 72 aylık takipte değerlendirildi. Bireysel kan gruplarına göre sağkalım analizinde; gruplar arasında istatistiksel olarak anlamlı fark yoktu. Hastalar iki gruba ayrıldığında, O kan grubu olanlarda % 24.39, O kan grubu olmayanlarda % 15.23 mortalite vardı (p> 0.05). İstatistiksel olarak anlamlı olmasa da, O kan grubundaki hastalarda 72 aylık mortalitede artış eğilimi gözlendi (p> 0.05). Bu çalışmada Rh antijeni ile sağkalım arasında bir ilişki yoktu (p = 0.79).Sonuç: İstatistiksel olarak anlamlılık sınırına ulaşamamasına rağmen, akut koroner sendromlu hastalarda O kan grubu olmayanlara göre O kan grubundaki hastalarda uzun dönem sağkalımda azalma eğilimi gözlenmiştir. Sonuçlar daha büyük prospektif çalışmalarla doğrulanmalıdır.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Liumbruno GM, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus. 2013;11(4):491-9. doi: 10.2450/2013.0152-13.
  • 2. Franchini M, Capra F, Targher G, et al. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J. 2007;5:14. doi: 10.1186/1477-9560-5-14.
  • 3. Whincup PH, Danesh J, Walker M, et al. von Willebrand factor and coronary heart disease: prospective study and metaanalysis. Eur Heart J. 2002;23:1764-70. doi: 10.1053/euhj.2001.3237.
  • 4. Franchini M, Lippi G. Von Willebrand factor and thrombosis. Ann Hematol. 2006;85:415-23. doi: 10.1007/s00277-006-0085-5.
  • 5. Franchini M, Makris M. Non-O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus. 2013;11(2):164-5. doi: 10.2450/2012.0087-12.
  • 6. Ohira T, Cushman M, Tsai MY, et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost. 2007;5:1455-61. doi: 10.1111/j.1538-7836.2007.02579.x.
  • 7. Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost. 2008;6:62-9. doi: 10.1111/j.1538-7836.2007.02818.x.
  • 8. Carpeggiani C, Coceani M, Landi P, et al. ABO blood group alleles: a risk factor for coronary artery disease. An angiographic study. Atherosclerosis. 2010;211: 461-6. doi: 10.1016/j.atherosclerosis.2010.03.012.
  • 9. Reilly MP, Li M, He J, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet. 2011;377(9763):383-92. doi: 10.1016/S0140-6736(10)61996-4.
  • 10. He M, Wolpin B, Rexrode K, et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol. 2012;32:2314-20. doi: 10.1161/ATVBAHA.112.248757.
  • 11. Johansson Å, et al. Genome-wide association study identifies that the abo blood group system influences interleukin-10 levels and the risk of clinical events in patients with acute coronary syndrome. PLoS One. 2015;10(11):e0142518. doi: 10.1371/journal.pone.0142518.
  • 12. Jager A, van Hinsbergh VW, Kostense PJ, et al. von Willebrand Factor, Creactive protein, and 5year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol. 1999;19(12):3071-8. doi: 10.1161/01.ATV.19.12.3071.
  • 13. Januszkiewicz Ł, Szczerba E, Paszkowska P, et al. Association of blood groups with prognosis in acute coronary syndrome. Pol Arch Med Wewn. 2013;123(9): 460-6. doi: 10.20452/pamw.1885.
APA Sahingoz Erdal G, Bıyık İ, Kasapoglu P, satılmışoğlu m, Isiksacan N (2021). Can our Blood Groups Determine our Life Expectancy?. , 48 - 52. 10.5222/BMJ.2021.43534
Chicago Sahingoz Erdal Gulcin,Bıyık İsmail,Kasapoglu Pinar,satılmışoğlu muhammet hulusi,Isiksacan Nilgun Can our Blood Groups Determine our Life Expectancy?. (2021): 48 - 52. 10.5222/BMJ.2021.43534
MLA Sahingoz Erdal Gulcin,Bıyık İsmail,Kasapoglu Pinar,satılmışoğlu muhammet hulusi,Isiksacan Nilgun Can our Blood Groups Determine our Life Expectancy?. , 2021, ss.48 - 52. 10.5222/BMJ.2021.43534
AMA Sahingoz Erdal G,Bıyık İ,Kasapoglu P,satılmışoğlu m,Isiksacan N Can our Blood Groups Determine our Life Expectancy?. . 2021; 48 - 52. 10.5222/BMJ.2021.43534
Vancouver Sahingoz Erdal G,Bıyık İ,Kasapoglu P,satılmışoğlu m,Isiksacan N Can our Blood Groups Determine our Life Expectancy?. . 2021; 48 - 52. 10.5222/BMJ.2021.43534
IEEE Sahingoz Erdal G,Bıyık İ,Kasapoglu P,satılmışoğlu m,Isiksacan N "Can our Blood Groups Determine our Life Expectancy?." , ss.48 - 52, 2021. 10.5222/BMJ.2021.43534
ISNAD Sahingoz Erdal, Gulcin vd. "Can our Blood Groups Determine our Life Expectancy?". (2021), 48-52. https://doi.org/10.5222/BMJ.2021.43534
APA Sahingoz Erdal G, Bıyık İ, Kasapoglu P, satılmışoğlu m, Isiksacan N (2021). Can our Blood Groups Determine our Life Expectancy?. Bakırköy Tıp Dergisi, 17(1), 48 - 52. 10.5222/BMJ.2021.43534
Chicago Sahingoz Erdal Gulcin,Bıyık İsmail,Kasapoglu Pinar,satılmışoğlu muhammet hulusi,Isiksacan Nilgun Can our Blood Groups Determine our Life Expectancy?. Bakırköy Tıp Dergisi 17, no.1 (2021): 48 - 52. 10.5222/BMJ.2021.43534
MLA Sahingoz Erdal Gulcin,Bıyık İsmail,Kasapoglu Pinar,satılmışoğlu muhammet hulusi,Isiksacan Nilgun Can our Blood Groups Determine our Life Expectancy?. Bakırköy Tıp Dergisi, vol.17, no.1, 2021, ss.48 - 52. 10.5222/BMJ.2021.43534
AMA Sahingoz Erdal G,Bıyık İ,Kasapoglu P,satılmışoğlu m,Isiksacan N Can our Blood Groups Determine our Life Expectancy?. Bakırköy Tıp Dergisi. 2021; 17(1): 48 - 52. 10.5222/BMJ.2021.43534
Vancouver Sahingoz Erdal G,Bıyık İ,Kasapoglu P,satılmışoğlu m,Isiksacan N Can our Blood Groups Determine our Life Expectancy?. Bakırköy Tıp Dergisi. 2021; 17(1): 48 - 52. 10.5222/BMJ.2021.43534
IEEE Sahingoz Erdal G,Bıyık İ,Kasapoglu P,satılmışoğlu m,Isiksacan N "Can our Blood Groups Determine our Life Expectancy?." Bakırköy Tıp Dergisi, 17, ss.48 - 52, 2021. 10.5222/BMJ.2021.43534
ISNAD Sahingoz Erdal, Gulcin vd. "Can our Blood Groups Determine our Life Expectancy?". Bakırköy Tıp Dergisi 17/1 (2021), 48-52. https://doi.org/10.5222/BMJ.2021.43534